Mkts

Vor Biopharma Inc.

NASDAQ: VOR
$17.83-0.35 (-1.93%)
As of Nov 18, 9:30 AM ET

Key statistics

Day range
17.7818.53
52-week range
6.5026.00
Today
Open17.85
Previous close17.83
Volume794.0K
Valuation
Market cap1.19B
P/E ratio0.88×
EPS (TTM)77.17
Income & risk
Dividend / yield—
Beta1.75
Avg volume702.0K
Discussion

VOR News

Stories mentioning VOR from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue
Cost of Goods Sold
Gross Profit0.000.000.000.000.000.000.000.00
Operating Expenses
Research & Development17,59519,19014,142261,49926,70125,34821,81721,823
Sales General & Admin
Total Operating Expenses35,16035,96028,107274,28433,29131,31128,51329,035
Operating Income (Loss)(35,160)(35,960)(28,107)(274,284)(33,291)(31,311)(28,513)(29,035)
Interest Income3,9352,7951,731537.00805.00599.00954.001,196
Interest Expense
Other Expense
Pretax Income
Tax Provision
Net Income (Loss)(219,585)1,722,858(812,684)(1,573,669)(32,486)(30,712)(27,559)(27,839)
Earnings Per Share (Basic)(5.11)174.52(121.63)(12.56)(5.21)(8.94)(8.05)(0.41)
Earnings Per Share (Diluted)(5.11)174.52(121.63)(12.56)(5.21)(8.94)(8.05)(0.41)
Weighted Average Shares Outstanding (Basic)43,0129,8726,682125,2716,2413,4363,42368,299
Weighted Average Shares Outstanding (Diluted)43,0129,8726,682125,2716,2413,4363,42368,299

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About VOR

Vor Biopharma Inc. (NASDAQ: VOR) is a stock listed on the Nasdaq Stock Market under the ticker symbol VOR. It last traded at $17.83 (Nov 18, 2026, 9:30 AM ET), down 1.9% on the day. That gives Vor Biopharma a market capitalisation of $1.2B and a price-to-earnings ratio of 0.9.

Over the past 52 weeks VOR has traded between $6.50 and $26.00.

For the quarter ended Mar 31, 2026 it reported a net loss of $219.6M.

Last 4 quarters
Quarter endedRevenueNet income
Mar 31, 2026—-$219.6M
Dec 31, 2025—$1.7B
Sep 30, 2025—-$812.7M
Jun 30, 2025—-$1.6B

From Vor Biopharma’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…